# A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors

> **NCT06394622** · PHASE1 · RECRUITING · sponsor: **Fudan University** · enrollment: 12 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **COMBINATION_PRODUCT:** Cyclophosphamide + Fludarabine + Infusion of CAR-NKT Cells

## Key facts

- **NCT ID:** NCT06394622
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-11
- **Primary completion:** 2026-06-28
- **Final completion:** 2026-06-28
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06394622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06394622, "A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06394622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*